IMC Chicago
BNTX icon

IMC Chicago’s BioNTech BNTX Stock Holding History

IMC Chicago’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
29,282
+1,711
+6% +$161K ﹤0.01% 2721
2026
Q1 		$2.45M Buy
27,571
+2,866
+12% +$295K ﹤0.01% 2382
2025
Q4 		$2.35M Buy
24,705
+7,299
+42% +$735K ﹤0.01% 2286
2025
Q3 		$1.72M Buy
+17,406
New +$1.86M ﹤0.01% 2339
2025
Q2 		– Sell
-31,508
Closed -$3.18M – 3306
2025
Q1 		$2.87M Buy
31,508
+18,204
+137% +$2.04M ﹤0.01% 1559
2024
Q4 		$1.52M Sell
13,304
-19,132
-59% -$2.18M ﹤0.01% 2071
2024
Q3 		$3.85M Sell
32,436
-3,718
-10% -$342K ﹤0.01% 1262
2024
Q2 		$2.91M Buy
36,154
+10,124
+39% +$925K ﹤0.01% 1346
2024
Q1 		$2.4M Buy
+26,030
New +$2.5M ﹤0.01% 1276
2022
Q3 		– Sell
-26,364
Closed -$4.03M – 1208
2022
Q2 		$3.93M Buy
26,364
+12,360
+88% +$1.89M 0.01% 583
2022
Q1 		$2.39M Sell
14,004
-1,423
-9% -$239K ﹤0.01% 735
2021
Q4 		$3.98M Sell
15,427
-11,495
-43% -$3.15M ﹤0.01% 664
2021
Q3 		$7.35M Buy
+26,922
New +$8.56M 0.01% 554

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

IMC Chicago's BNTX Position: Q2 2026 in Review

IMC Chicago increased its BioNTech (BNTX) stake by 6.2% in Q2 2026, buying an estimated $161K and bringing the position to 29,282 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

IMC Chicago first reported a position in BNTX in Q3 2021 and has held it in 13 quarters since. The position peaked at $7.35M in Q3 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • IMC Chicago held 29,282 shares of BioNTech worth $2.72M as of Q2 2026.
  • IMC Chicago bought 1,711 BioNTech shares in Q2 2026, an estimated $161K.
  • BioNTech made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2721 holding.
  • IMC Chicago first reported a position in BioNTech in Q3 2021 and has held it in 13 quarters since.
  • IMC Chicago's BioNTech position peaked at $7.35M in Q3 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.